HIV Prevention

Disease State Hub

Featured

Conference Coverage

Conference Coverage

The Future of Multipurpose Prevention Technologies

05/23/2023

Pop Quiz

Significant Gains in PrEP Use Among Recommended Users

05/17/2023

According to the CDC, pre-exposure prophylaxis (PrEP) use among recommended users jumped significantly between 2015 and 2020. What was the percentage of PrEP users in 2020? Take the quiz and find out!

05/17/2023

Expert Q&A

HIV Therapy and Prevention

05/10/2023

PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.

05/10/2023

Interactive Features

Pop Quiz

Significant Gains in PrEP Use Among Recommended Users

05/17/2023

pop quiz

Common Barriers to PrEP Uptake

03/14/2023

Pop Quiz

Testing for Pregnancy in Women Using PrEP

02/24/2023

The CDC guidelines on pre-exposure prophylaxis use include a recommendation on the frequency of testing for pregnancy among women who intend to become pregnant and are taking PrEP. Are you familiar with...

02/24/2023

Pop Quiz

Informing Patients About PrEP

12/21/2022

Test Your Knowledge

Test Your Knowledge

Managing a High-Risk, Young Patient

11/21/2022

In this Test Your Knowledge quiz, Diana Finkel, DO, poses a clinical scenario and asks you how you would manage this patient who is at high risk for HIV and is attending college for the first time.

11/21/2022

Clinical Insights

Conference Coverage

The Future of Multipurpose Prevention Technologies

05/23/2023

Expert Q&A

HIV Therapy and Prevention

05/10/2023

PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.

05/10/2023

Podcast

Podcast

The Benefits of HIV PrEP for Women

04/12/2023

Video

Video

Implementing the PrEP & PEP Toolkit

04/10/2023

In this video, Colleen F. Kelley, MD, MPH, speaks about incorporating pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) into clinical practice, including strategies for clinicians, current...

04/10/2023

Podcast

The Future of HIV PrEP Research

03/28/2023

HIV Prevention Snapshot

Reviewed by Daniel Erias, MD and Jeffrey Kwong, DNP, MPH, AGPCNP-BC

Overview

Pre-exposure prophylaxis (PrEP) is a preventive medication administered intravenously or orally to reduce the risk of human immunodeficiency virus (HIV) infection that may occur following sex or injection drug use.

Specialty Impact

Any licensed health care provider is able to prescribe PrEP. Among the health care providers who are most likely to prescribe PrEP are:

At-Risk Populations

Individuals who are at-risk of HIV transmission include:

Individuals who have had anal or vaginal sex in the past 6 months and
- had a parter with HIV
- had sex without consistently using a condom
- have been diagnosed with a sexually transmitted disease in the past 6 months
Individuals who inject drugs, have an injection partner with HIV, or who shares needles, syringes, or other drug injection equipment
Individuals who have previously been prescribed PrEP, have reported continued risk behavior, or previously used multiple courses of PrEP

Diagnostic Snapshot

The HIV Risk Incidence Index for Men Who Have Sex With Men (HIRI-MSM) and Injection Drug Users Risk Index (IDU) are often used to stratify risk in patients.

Patient Data

Sources:

Research Summaries

research summary

Individuals Seeking Mpox Vaccination Are Also at Increased Risk of STIs, HIV

04/27/2023

Leigh Precopio

Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.

04/27/2023

CONFERENCE CONVERAGE